IgG1κ monoclonal antibodies Secukinumab Cas 1229022-83-6
Price:
Negotiable
MOQ:
1g
Delivery Time:
Negotiable
Brand:
Crene
Product Description
IgG1κ monoclonal antibodies Secukinumab Cas 1229022-83-6
Chemical Information
| Product name:Secukinumab | Purity:95% min |
| CAS NO:1229022-83-6 | Solubility:Soluble in DMSO |
| Molecular Formula:C6584H10134N1754O2042S44 | Package:Package according to customer requirements. |
| Molecular Weight:147.94 kg/mol g/mol | Storage:Store at -20℃ |
Quality control
COA
Remarks
Secukinumab, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A.
Related Prodcuts:
Pembrolimumab; Infliximab; Ramucirumab; Ipilimumab; Atezolizumab; Daratumumab; Dulaglutide; Rituximab; Adalimumab; Nivolumab; Denosumab; Cetuximab; Bevacizumab; Aflibercept
Similar Products
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.
Company
Taizhou Crene Biotechnology Co., Ltd.
Location
Add: Economic Developed Zone of Taizhou Zhejiang China.